166 related articles for article (PubMed ID: 25617169)
1. Mineralocorticoid substitution and monitoring in primary adrenal insufficiency.
Quinkler M; Oelkers W; Remde H; Allolio B
Best Pract Res Clin Endocrinol Metab; 2015 Jan; 29(1):17-24. PubMed ID: 25617169
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis and therapy surveillance in Addison's disease: rapid adrenocorticotropin (ACTH) test and measurement of plasma ACTH, renin activity, and aldosterone.
Oelkers W; Diederich S; Bähr V
J Clin Endocrinol Metab; 1992 Jul; 75(1):259-64. PubMed ID: 1320051
[TBL] [Abstract][Full Text] [Related]
3. The role of plasma renin activity in evaluating the adequacy of mineralocorticoid replacement in primary adrenal insufficiency.
Flad TM; Conway JD; Cunningham SK; McKenna TJ
Clin Endocrinol (Oxf); 1996 Nov; 45(5):529-34. PubMed ID: 8977748
[TBL] [Abstract][Full Text] [Related]
4. Use of plasma renin activity to monitor mineralocorticoid treatment in dogs with primary hypoadrenocorticism: desoxycorticosterone versus fludrocortisone.
Baumstark ME; Nussberger J; Boretti FS; Baumstark MW; Riond B; Reusch CE; Sieber-Ruckstuhl NS
J Vet Intern Med; 2014; 28(5):1471-8. PubMed ID: 25274440
[TBL] [Abstract][Full Text] [Related]
5. Atrial natriuretic peptide and plasma renin levels in assessment of mineralocorticoid replacement in Addison's disease.
Cohen N; Gilbert R; Wirth A; Casley D; Jerums G
J Clin Endocrinol Metab; 1996 Apr; 81(4):1411-5. PubMed ID: 8636343
[TBL] [Abstract][Full Text] [Related]
6. [Pharmacological action of 9alpha-fluorohydrocortisone as a mineralocorticoid].
Sekihara H
Nihon Rinsho; 1994 Mar; 52(3):583-6. PubMed ID: 8164353
[TBL] [Abstract][Full Text] [Related]
7. Mineralocorticoid replacement in Addison's disease.
Thompson DG; Mason AS; Goodwin FJ
Clin Endocrinol (Oxf); 1979 May; 10(5):499-506. PubMed ID: 476980
[TBL] [Abstract][Full Text] [Related]
8. [Fludrocortisone substitution in adrenal cortex insufficiency].
Jungmann E; Althoff PH; Schöffling K
Dtsch Med Wochenschr; 1985 May; 110(21):850-1. PubMed ID: 3888590
[No Abstract] [Full Text] [Related]
9. Modified-release hydrocortisone is associated with lower plasma renin activity in patients with salt-wasting congenital adrenal hyperplasia.
Tschaidse L; Reisch N; Arlt W; Brac de la Perriere A; Linden Hirschberg A; Juul A; Mallappa A; Merke DP; Newell-Price JDC; Perry CG; Prete A; Rees DA; Stikkelbroeck NMML; Touraine PA; Coope H; Porter J; Ross RJM; Quinkler M
Eur J Endocrinol; 2023 Jan; 188(1):. PubMed ID: 36654495
[TBL] [Abstract][Full Text] [Related]
10. Hyponatremia in a Teenager: A Rare Diagnosis.
Correia F; Fernandes A; Mota TC; Garcia M; Castro-Correia C; Fontoura M; Ribeiro A
Pediatr Emerg Care; 2015 Dec; 31(12):860-3. PubMed ID: 26626895
[TBL] [Abstract][Full Text] [Related]
11. Control of mineralocorticoid substitution in Addison's disease by plasma renin measurement.
Oelkers W; L'age M
Klin Wochenschr; 1976 Jul; 54(13):607-12. PubMed ID: 940296
[TBL] [Abstract][Full Text] [Related]
12. Plasma aldosterone, renin activity, and 17alpha-hydroxyprogesterone in salt-losing congenital adrenal hyperplasia. I. Response to ACTH in hydrocortisone treated patients and effect of 9alpha-fluorocortisol.
Limal JM; Rappaport R; Bayard F
J Clin Endocrinol Metab; 1977 Sep; 45(3):551-9. PubMed ID: 198427
[No Abstract] [Full Text] [Related]
13. Mineralocorticoids in the management of primary adrenocortical insufficiency.
Jadoul M; Ferrant A; De Plaen JF; Crabbé J
J Endocrinol Invest; 1991 Feb; 14(2):87-91. PubMed ID: 2061574
[TBL] [Abstract][Full Text] [Related]
14. Effects of fludrocortisone withdrawal on plasma angiotensin II, ACTH, vasopressin, and potassium in patients with Addison's disease.
Oelkers W; Bähr V
Acta Endocrinol (Copenh); 1987 Jul; 115(3):325-30. PubMed ID: 3039766
[TBL] [Abstract][Full Text] [Related]
15. Primary Adrenal Insufficiency: Managing Mineralocorticoid Replacement Therapy.
Esposito D; Pasquali D; Johannsson G
J Clin Endocrinol Metab; 2018 Feb; 103(2):376-387. PubMed ID: 29156052
[TBL] [Abstract][Full Text] [Related]
16. Familial hyperkalemia, hypertension, and hyporeninemia with normal aldosterone levels. A tubular defect in potassium handling.
Brautbar N; Levi J; Rosler A; Leitesdorf E; Djaldeti M; Epstein M; Kleeman CR
Arch Intern Med; 1978 Apr; 138(4):607-10. PubMed ID: 637641
[TBL] [Abstract][Full Text] [Related]
17. Hyporeninemic hypoaldosteronism, sodium wasting and mineralocorticoid-resistant hyperkalemia in two patients with obstructive uropathy.
Pelleya R; Oster JR; Perez GO
Am J Nephrol; 1983; 3(4):223-7. PubMed ID: 6351617
[TBL] [Abstract][Full Text] [Related]
18. Evidence that patients with Addison's disease are undertreated with fludrocortisone.
Smith SJ; MacGregor GA; Markandu ND; Bayliss J; Banks RA; Prentice MG; Dorrington-Ward P; Wise P
Lancet; 1984 Jan; 1(8367):11-4. PubMed ID: 6140341
[TBL] [Abstract][Full Text] [Related]
19. Addison's disease.
Nieman LK; Chanco Turner ML
Clin Dermatol; 2006; 24(4):276-80. PubMed ID: 16828409
[TBL] [Abstract][Full Text] [Related]
20. Management of adrenal insufficiency in different clinical settings.
Hahner S; Allolio B
Expert Opin Pharmacother; 2005 Nov; 6(14):2407-17. PubMed ID: 16259572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
